SK-BR-3
<p>EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells</p>
16
Silibinin: An Inhibitor of Mir-181a Gene Expression in Sk-Br-3 Breast Cancer Cell Line
6
PRODUCTIO N OF PROSTATE-SPECIFIC ANTIGEN (PSA) BY A BREAST CANCER CELL LINE, SK-Br-3
6
Lists in a Lighthouse
136
miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer
8
Study of the Effect of Silymarin on Viability of Breast Cancer Cell Lines
7
Silicon particles as trojan horses for potential cancer therapy
10
Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes
9
Near-infrared quantum dots for HER2 localization and imaging of cancer cells
15
Original Article Effects of chitosan nanoparticle carrier-mediated small-interfering RNA silencing of SUMO-specific protease 1 on in vitro migration of breast cancer cells
6
Cleavage of the extracellular domain of junctional adhesion molecule A is associated with resistance to anti HER2 therapies in breast cancer settings
18
Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER−/Her2+ breast cancer
12
Murine precision-cut liver slices (PCLS): a new tool for studying tumor microenvironments and cell signaling ex vivo
13
Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia
12
Genetically Encoded Immunophotosensitizer 4D5scFv-miniSOG is a Highly Selective Agent for Targeted Photokilling of Tumor Cells in Vitro
10
HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo
13
Anti-neoplastic effects of aprotinin on human breast cancer cell lines: In vitro study
7
Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells
21
Original Article Detection of HER2 positive circulating tumor cells using anti-HER2-renilla luciferase fusion protein
14
The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling
13